Atlantic Research Group
Private Company
Funding information not available
Overview
Atlantic Research Group (ARG) is a specialized Contract Research Organization (CRO) with a strong track record in managing complex clinical trials, particularly in oncology, immunology, and neurology. The company emphasizes a flexible, collaborative approach and boasts a high rate of repeat business. Its recent merger with Evestia Clinical positions it as part of a larger, global specialist CRO aiming to enhance service capabilities and geographic reach.
Technology Platform
Integrated clinical trial operational processes with a focus on customization and exploration of generative AI applications.
Opportunities
Risk Factors
Competitive Landscape
ARG operates in the highly competitive global CRO market, competing with large full-service CROs (IQVIA, PPD, ICON) and smaller niche players. Its differentiator has been a flexible, therapeutic-area-focused approach, a position now amplified through its merger to create a scaled specialist competitor.